5-aza-2′-deoxycytidine activates iron uptake and heme biosynthesis by increasing c-Myc nuclear localization and binding to the E-boxes of Transferrin Receptor 1 (TfR1) and ferrochelatase (Fech) genes

Bo Ning, Gang Liu, Yuanyuan Liu, Xiufen Su, Gregory J. Anderson, Xin Zheng, Yanzhong Chang, Mingzhou Guo, Yuanfang Liu, Yuliang Zhao, Guangjun Nie

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The hypomethylating agent 5-aza-2′-deoxycytidine (5-aza-CdR) and its derivatives have been successfully used for the treatment of myelodysplastic syndromes, and they frequently improve the anemia that usually accompanies these disorders. However, the molecular mechanisms underlying this action remain poorly understood. In this study, we used two erythroid models, murine erythroid leukemia cells and erythroid burst-forming unit-derived erythroblasts, to show that 5-aza-CdR induced erythroid differentiation and increased the expression of transferrin receptor 1 (TfR1) and ferrochelatase (Fech), thereby increasing iron uptake and heme biosynthesis. We have identified new regulatory E-boxes that lie outside of CpG islands in the TfR1 and Fech promoters, and the methylation status of these sites can be altered by 5-aza-CdR treatment. This in turn altered the binding of the transcription factor c-Myc to these promoter elements. Furthermore, 5-aza-CdR promoted the nuclear translocation of c-Myc and its binding toMaxto form functional complexes. The coordinated actions of 5-aza-CdR on the methylation status of the target genes and in stimulating the nuclear translocation of c-Mycprovide new molecular insights into the regulation of E-boxes and explain, at least in part, the increased erythroid response to 5-aza-CdR treatment.

Original languageEnglish (US)
Pages (from-to)37196-37206
Number of pages11
JournalJournal of Biological Chemistry
Volume286
Issue number43
DOIs
StatePublished - Oct 28 2011
Externally publishedYes

Fingerprint

decitabine
Ferrochelatase
Transferrin Receptors
Methylation
Biosynthesis
Heme
Iron
Genes
Erythroblasts
Erythroid Precursor Cells
Erythroid Cells
CpG Islands
Myelodysplastic Syndromes
Anemia
Leukemia
Transcription Factors
Derivatives

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

5-aza-2′-deoxycytidine activates iron uptake and heme biosynthesis by increasing c-Myc nuclear localization and binding to the E-boxes of Transferrin Receptor 1 (TfR1) and ferrochelatase (Fech) genes. / Ning, Bo; Liu, Gang; Liu, Yuanyuan; Su, Xiufen; Anderson, Gregory J.; Zheng, Xin; Chang, Yanzhong; Guo, Mingzhou; Liu, Yuanfang; Zhao, Yuliang; Nie, Guangjun.

In: Journal of Biological Chemistry, Vol. 286, No. 43, 28.10.2011, p. 37196-37206.

Research output: Contribution to journalArticle

Ning, Bo ; Liu, Gang ; Liu, Yuanyuan ; Su, Xiufen ; Anderson, Gregory J. ; Zheng, Xin ; Chang, Yanzhong ; Guo, Mingzhou ; Liu, Yuanfang ; Zhao, Yuliang ; Nie, Guangjun. / 5-aza-2′-deoxycytidine activates iron uptake and heme biosynthesis by increasing c-Myc nuclear localization and binding to the E-boxes of Transferrin Receptor 1 (TfR1) and ferrochelatase (Fech) genes. In: Journal of Biological Chemistry. 2011 ; Vol. 286, No. 43. pp. 37196-37206.
@article{ef56be0dde134207984da3c2f7e48318,
title = "5-aza-2′-deoxycytidine activates iron uptake and heme biosynthesis by increasing c-Myc nuclear localization and binding to the E-boxes of Transferrin Receptor 1 (TfR1) and ferrochelatase (Fech) genes",
abstract = "The hypomethylating agent 5-aza-2′-deoxycytidine (5-aza-CdR) and its derivatives have been successfully used for the treatment of myelodysplastic syndromes, and they frequently improve the anemia that usually accompanies these disorders. However, the molecular mechanisms underlying this action remain poorly understood. In this study, we used two erythroid models, murine erythroid leukemia cells and erythroid burst-forming unit-derived erythroblasts, to show that 5-aza-CdR induced erythroid differentiation and increased the expression of transferrin receptor 1 (TfR1) and ferrochelatase (Fech), thereby increasing iron uptake and heme biosynthesis. We have identified new regulatory E-boxes that lie outside of CpG islands in the TfR1 and Fech promoters, and the methylation status of these sites can be altered by 5-aza-CdR treatment. This in turn altered the binding of the transcription factor c-Myc to these promoter elements. Furthermore, 5-aza-CdR promoted the nuclear translocation of c-Myc and its binding toMaxto form functional complexes. The coordinated actions of 5-aza-CdR on the methylation status of the target genes and in stimulating the nuclear translocation of c-Mycprovide new molecular insights into the regulation of E-boxes and explain, at least in part, the increased erythroid response to 5-aza-CdR treatment.",
author = "Bo Ning and Gang Liu and Yuanyuan Liu and Xiufen Su and Anderson, {Gregory J.} and Xin Zheng and Yanzhong Chang and Mingzhou Guo and Yuanfang Liu and Yuliang Zhao and Guangjun Nie",
year = "2011",
month = "10",
day = "28",
doi = "10.1074/jbc.M111.258129",
language = "English (US)",
volume = "286",
pages = "37196--37206",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "43",

}

TY - JOUR

T1 - 5-aza-2′-deoxycytidine activates iron uptake and heme biosynthesis by increasing c-Myc nuclear localization and binding to the E-boxes of Transferrin Receptor 1 (TfR1) and ferrochelatase (Fech) genes

AU - Ning, Bo

AU - Liu, Gang

AU - Liu, Yuanyuan

AU - Su, Xiufen

AU - Anderson, Gregory J.

AU - Zheng, Xin

AU - Chang, Yanzhong

AU - Guo, Mingzhou

AU - Liu, Yuanfang

AU - Zhao, Yuliang

AU - Nie, Guangjun

PY - 2011/10/28

Y1 - 2011/10/28

N2 - The hypomethylating agent 5-aza-2′-deoxycytidine (5-aza-CdR) and its derivatives have been successfully used for the treatment of myelodysplastic syndromes, and they frequently improve the anemia that usually accompanies these disorders. However, the molecular mechanisms underlying this action remain poorly understood. In this study, we used two erythroid models, murine erythroid leukemia cells and erythroid burst-forming unit-derived erythroblasts, to show that 5-aza-CdR induced erythroid differentiation and increased the expression of transferrin receptor 1 (TfR1) and ferrochelatase (Fech), thereby increasing iron uptake and heme biosynthesis. We have identified new regulatory E-boxes that lie outside of CpG islands in the TfR1 and Fech promoters, and the methylation status of these sites can be altered by 5-aza-CdR treatment. This in turn altered the binding of the transcription factor c-Myc to these promoter elements. Furthermore, 5-aza-CdR promoted the nuclear translocation of c-Myc and its binding toMaxto form functional complexes. The coordinated actions of 5-aza-CdR on the methylation status of the target genes and in stimulating the nuclear translocation of c-Mycprovide new molecular insights into the regulation of E-boxes and explain, at least in part, the increased erythroid response to 5-aza-CdR treatment.

AB - The hypomethylating agent 5-aza-2′-deoxycytidine (5-aza-CdR) and its derivatives have been successfully used for the treatment of myelodysplastic syndromes, and they frequently improve the anemia that usually accompanies these disorders. However, the molecular mechanisms underlying this action remain poorly understood. In this study, we used two erythroid models, murine erythroid leukemia cells and erythroid burst-forming unit-derived erythroblasts, to show that 5-aza-CdR induced erythroid differentiation and increased the expression of transferrin receptor 1 (TfR1) and ferrochelatase (Fech), thereby increasing iron uptake and heme biosynthesis. We have identified new regulatory E-boxes that lie outside of CpG islands in the TfR1 and Fech promoters, and the methylation status of these sites can be altered by 5-aza-CdR treatment. This in turn altered the binding of the transcription factor c-Myc to these promoter elements. Furthermore, 5-aza-CdR promoted the nuclear translocation of c-Myc and its binding toMaxto form functional complexes. The coordinated actions of 5-aza-CdR on the methylation status of the target genes and in stimulating the nuclear translocation of c-Mycprovide new molecular insights into the regulation of E-boxes and explain, at least in part, the increased erythroid response to 5-aza-CdR treatment.

UR - http://www.scopus.com/inward/record.url?scp=80054822255&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054822255&partnerID=8YFLogxK

U2 - 10.1074/jbc.M111.258129

DO - 10.1074/jbc.M111.258129

M3 - Article

VL - 286

SP - 37196

EP - 37206

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 43

ER -